EyePoint, Inc. (EYPT)
3.65
-0.07
(-1.88%)
USD |
NASDAQ |
Sep 24, 16:00
3.76
+0.11
(+3.01%)
After-Hours: 05:52
EyePoint Gross Profit (Annual) : 27.00M for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 27.00M |
| December 31, 2024 | 39.56M |
| December 31, 2023 | 41.39M |
| December 31, 2022 | 31.03M |
| December 31, 2021 | 26.30M |
| December 31, 2020 | 26.15M |
| December 31, 2019 | 15.22M |
| December 31, 2018 | 0.00 |
| June 30, 2017 | 6.724M |
| June 30, 2016 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2015 | 0.00 |
| June 30, 2014 | 0.00 |
| June 30, 2013 | 0.00 |
| June 30, 2012 | 0.00 |
| June 30, 2011 | 1.61M |
| June 30, 2010 | 19.73M |
| June 30, 2009 | 0.00 |
| June 30, 2008 | 0.00 |
| June 30, 2007 | -9.229M |
| June 30, 2006 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Ocular Therapeutix, Inc. | 45.38M |
| Eli Lilly & Co. | 54.13B |
| Elanco Animal Health, Inc. | 2.05B |
| Amylyx Pharmaceuticals, Inc. | -0.525M |
| Nuvation Bio, Inc. | 51.86M |